April 19, 2023
The University of Cincinnati's Alberto Espay was featured in a MedPage Today article commenting on a recent review that found functional neurological disorder is often misunderstood and needs further recognition and parity in medical education, research and clinical service.
December 9, 2022
The University of Cincinnati's Pooja Khatri spoke with CNN about a recent study that found statins can reduce the risk of an intracerebral hemorrhage.
October 10, 2022
Local 12 News and 55KRC's Simply Medicine podcast highlighted the the University of Cincinnati Gardner Neuroscience Institute's transformation into a Learning Health System, beginning with work in epilepsy.
January 10, 2023
Parkinson's News Today highlighted results of a recent trial, led in the U.S. by the University of Cincinnati's Alberto Espay, that found a liquid drug formulation was more effective than an oral formulation to control symptoms of Parkinson's disease.
February 14, 2023
The University of Cincinnati's Joseph Broderick provided comments to Medscape about new trial data that found performing endovascular thrombectomy in stroke patients with a large ischemic core is beneficial.
November 1, 2023
The University of Cincinnati's David Ficker spoke with Fox 19 about medical-related vehicle crashes.
November 9, 2023
The Cincinnati Business Courier highlighted the UC Gardner Neuroscience Institute's recent renewal to continue to serve as the National Coordinating Center for the National Institutes of Health StrokeNet program that conducts clinical trials and research studies to advance stroke treatment, prevention and recovery.
March 18, 2024
WCPO highlighted the Steps for Stroke 2024 event, raising money to advance stroke research at the University of Cincinnati.
March 4, 2024
The University of Cincinnati's Oluwole Awosika commented to Medscape on a new study that found a vibrating glove device could help manage hand spasticity symptoms after a stroke.
March 19, 2024
MSN and Neurology Live covered the results of a phase 3 trial co-led by a University of Cincinnati researcher that found Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing symptoms for longer periods of time.